Frontlight ResearchEarly access
Not yet recruitingEarly phase 1
Effect of Remimazolam Versus Dexmedetomidine on the Incidence of Delirium After Elective Cardiac Surgery with Cardiopulmonary Bypass: a Prospective Randomized Controlled Trial
Key facts
- Who runs it
- Assiut University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Early phase 1
- People taking part
- 111 people, planned
- Started
- 10 Jan 2025
- Expected to end
- 1 Nov 2027
- Type of study
- Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Propofol Group 1
- Remimazolam Intervention
- Dexmedetomidine Intervention
- Record updated
- 1 January 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age ≥18 years
- Scheduled for cardiac surgery (CABG and/or valve replacement)
- Elective surgery
Who cannot take part
- Patients with known allergies to Remimazolam or Dexmedetomidine
- History of psychiatric or neurological conditions (schizophrenia, epilepsy, severe dementia, etc.)
- Refusal to participate
- Preoperative inability to communicate (severe visual/auditory dysfunction, language barriers)
- Severe hepatic or renal dysfunction
- Cardiopulmonary bypass time not ≥ 120 minutes
- aortic clamping time not ≥ 90 minutes
- Emergency surgeries
- On preoperative mechanical ventilation and long sedation time
- reoperated patients
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The study aims to improve the post-open heart surgery lifestyle and overall experience, as well as assess the incidence of delirium using Remimazolam and Dexmedetomidine.
The 3 groups in the trial
- Group 1 : propofol groupPlacebo, for comparison
Postoperative Use
Treatment: Propofol Group 1
- Group 2: Remimazolam InterventionTreatment being tested
Postoperative Use
Treatment: Remimazolam Intervention
- Group 3: Dexmedetomidine InterventionTreatment being tested
Postoperative Use
Treatment: Dexmedetomidine Intervention
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 1 January 2025